Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 19, 2021CHEST JournalOpen Access

Reboxetine Plus Oxybutynin for OSA Treatment

View Full Paper
Ask AI
Bookmark
Share

Authors

EPElisa PergerLTLuigi Taranto‐MontemurroDRDébora Rosa

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Perger et al. (2021) studied this question.

synapsesocial.com/papers/6a9798d31048ae47fb76f484https://doi.org/10.1016/j.chest.2021.08.080
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Determinants of Ventilatory Instability in Obstructive Sleep Apnea: Inherent or Acquired?2009 · 149 citations
  2. 20227 Sleep Deprivation Enlarges Inter-stimulus Interval Effect On Vigilant Attention2018 · 3 citations
  3. 3Anticholinergics for Overactive Bladder Therapy: Central Nervous System Effects2011 · 116 citations
  4. 4Sleep deprivation enhances inter-stimulus interval effect on vigilant attention performance2018 · 34 citations
  5. 5The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double‐blind, placebo‐controlled, randomised crossover trial2021 · 70 citations